HCAT Quote, Financials, Valuation and Earnings

Amedisys has a net margin of -19.29% compared to Health Catalyst's net margin of 2.88%. Health Catalyst's return on equity of -21.76% beat Amedisys's return on equity of 7.23%.

Health Catalyst has a consensus price target of --, signalling upside risk potential of 62.76%. On the other hand Amedisys has an analysts' consensus of $96.86 which suggests that it could grow by 7.04%. Given that Health Catalyst has higher upside potential than Amedisys, analysts believe Health Catalyst is more attractive than Amedisys.

Health Catalyst has a beta of 1.315, which suggesting that the stock is 31.457% more volatile than S&P 500. In comparison Amedisys has a beta of 0.726, suggesting its less volatile than the S&P 500 by 27.385%.

Health Catalyst has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amedisys offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst pays -- of its earnings as a dividend. Amedisys pays out -- of its earnings as a dividend.

Health Catalyst quarterly revenues are $76.4M, which are smaller than Amedisys quarterly revenues of $587.7M. Health Catalyst's net income of -$14.7M is lower than Amedisys's net income of $16.9M. Notably, Health Catalyst's price-to-earnings ratio is -- while Amedisys's PE ratio is 36.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst is 1.37x versus 1.29x for Amedisys. Usually stocks with elevated PS ratios are considered overvalued.

Option Care Health has a net margin of -19.29% compared to Health Catalyst's net margin of 4.21%. Health Catalyst's return on equity of -21.76% beat Option Care Health's return on equity of 14.65%.

Health Catalyst has a consensus price target of --, signalling upside risk potential of 62.76%. On the other hand Option Care Health has an analysts' consensus of -- which suggests that it could grow by 32.88%. Given that Health Catalyst has higher upside potential than Option Care Health, analysts believe Health Catalyst is more attractive than Option Care Health.

Health Catalyst has a beta of 1.315, which suggesting that the stock is 31.457% more volatile than S&P 500. In comparison Option Care Health has a beta of 1.332, suggesting its more volatile than the S&P 500 by 33.16%.

Health Catalyst has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Option Care Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst pays -- of its earnings as a dividend. Option Care Health pays out -- of its earnings as a dividend.

Health Catalyst quarterly revenues are $76.4M, which are smaller than Option Care Health quarterly revenues of $1.3B. Health Catalyst's net income of -$14.7M is lower than Option Care Health's net income of $53.9M. Notably, Health Catalyst's price-to-earnings ratio is -- while Option Care Health's PE ratio is 19.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst is 1.37x versus 0.83x for Option Care Health. Usually stocks with elevated PS ratios are considered overvalued.

OptimizeRx has a net margin of -19.29% compared to Health Catalyst's net margin of -42.82%. Health Catalyst's return on equity of -21.76% beat OptimizeRx's return on equity of -20.12%.

Health Catalyst has a consensus price target of --, signalling upside risk potential of 62.76%. On the other hand OptimizeRx has an analysts' consensus of $9.79 which suggests that it could grow by 85.34%. Given that OptimizeRx has higher upside potential than Health Catalyst, analysts believe OptimizeRx is more attractive than Health Catalyst.

Health Catalyst has a beta of 1.315, which suggesting that the stock is 31.457% more volatile than S&P 500. In comparison OptimizeRx has a beta of 1.341, suggesting its more volatile than the S&P 500 by 34.097%.

Health Catalyst has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OptimizeRx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst pays -- of its earnings as a dividend. OptimizeRx pays out -- of its earnings as a dividend.

Health Catalyst quarterly revenues are $76.4M, which are larger than OptimizeRx quarterly revenues of $21.3M. Health Catalyst's net income of -$14.7M is lower than OptimizeRx's net income of -$9.1M. Notably, Health Catalyst's price-to-earnings ratio is -- while OptimizeRx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst is 1.37x versus 1.09x for OptimizeRx. Usually stocks with elevated PS ratios are considered overvalued.

Regional Health Properties has a net margin of -19.29% compared to Health Catalyst's net margin of -23.24%. Health Catalyst's return on equity of -21.76% beat Regional Health Properties's return on equity of -489.72%.

Health Catalyst has a consensus price target of --, signalling upside risk potential of 62.76%. On the other hand Regional Health Properties has an analysts' consensus of -- which suggests that it could grow by 324.84%. Given that Regional Health Properties has higher upside potential than Health Catalyst, analysts believe Regional Health Properties is more attractive than Health Catalyst.

Health Catalyst has a beta of 1.315, which suggesting that the stock is 31.457% more volatile than S&P 500. In comparison Regional Health Properties has a beta of 0.916, suggesting its less volatile than the S&P 500 by 8.446%.

Health Catalyst has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Regional Health Properties offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Health Catalyst pays -- of its earnings as a dividend. Regional Health Properties pays out -- of its earnings as a dividend.

Health Catalyst quarterly revenues are $76.4M, which are larger than Regional Health Properties quarterly revenues of $4.2M. Health Catalyst's net income of -$14.7M is lower than Regional Health Properties's net income of -$982K. Notably, Health Catalyst's price-to-earnings ratio is -- while Regional Health Properties's PE ratio is 0.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Health Catalyst is 1.37x versus 0.17x for Regional Health Properties. Usually stocks with elevated PS ratios are considered overvalued.